Results 231 to 240 of about 70,369 (254)

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial

Autophagy, 2021
Inge Compter, Kasper M A Rouschop, L Ackermans   +2 more
exaly  

Temozolomide

Reactions Weekly, 2018
  +4 more sources

Comprehensive pharmacogenomics characterization of temozolomide response in gliomas

European Journal of Pharmacology, 2021
Jian Wu
exaly  

Temozolomide

Reactions Weekly, 2002
openaire   +1 more source

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients

Annals of Oncology, 2009
Markus Pfirrmann, Thomas Illmer, Curt Dill   +2 more
exaly  

Temozolomide

Reactions Weekly, 2014
openaire   +2 more sources

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Lancet, The, 2019
Ulrich Herrlinger, Theophilos Tzaridis, Frédéric Mack   +2 more
exaly  

Temozolomide

Reactions Weekly, 2017
openaire   +1 more source

Temozolomide

Reactions Weekly, 2013
  +4 more sources

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

Annals of Oncology, 2003
M Brada, D Traish
exaly